FI
Insider
Fosun Pharma USA Inc.
10% ownerFosun Pharma USA Inc. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in Nature's Sunshine Products, Inc. (NATR). The largest single filing was $32.7M of NATR (2,854,607 sh × $11.46, as filed), executed Jun 27 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$32.7M
shares × price, as filed
Last traded
Jun 27 2025
Filed Jun 27 2025
Median ADV $2.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $32.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Consumer Defensive
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NATR
Nature's Sunshine Products, Inc.
NATR · 0 buys · 1 sell
1 filing
Recent filings
NATRSALE
Nature's Sunshine Products, Inc.
View filing →
$32.7M2,854,607 sh × $11.46
Exec Jun 27 2025
Filed Jun 27 2025 · 5:30 PM ET